Bvf Inc Aadi Bioscience, Inc. Transaction History

Bvf Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$6.85 - $13.0 $1.67 Million - $3.17 Million	-244,104 Reduced 43.41%	318,205 $2.3 Million
Q4 2022 Feb 14, 2023	SELL	$11.99 - $14.5 $3.8 Million - $4.59 Million	-316,776 Reduced 36.03%	562,309 $7.21 Million
Q1 2022 May 16, 2022	SELL	$16.65 - $24.97 $338,111 - $507,065	-20,307 Reduced 2.26%	879,085 $14.9 Million
Q4 2021 Feb 14, 2022	SELL	$19.32 - $29.02 $4.78 Million - $7.19 Million	-247,660 Reduced 21.59%	899,392 $21.7 Million
Q3 2021 Nov 15, 2021	BUY	$25.52 - $41.85 $29.3 Million - $48 Million	1,147,052 New	1,147,052 $33.7 Million

12.6M

23.8K

Ticker AADI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,016,800
Market Cap $78.4M
Description
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

Stay updated on Bvf Inc with notifications on news.